Nishida K, Ohta Y, Ishiguro I
Department of Biochemistry, School of Medicine, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.
Pharmacol Res. 1999 Apr;39(4):325-32. doi: 10.1006/phrs.1998.0448.
Recently, we demonstrated that teprenone, an anti-ulcer agent, exerts protective and preventive actions against water immersion restraint (WIR) stress-induced gastric mucosal lesions in rats both by inhibiting neutrophil infiltration into the gastric mucosal tissue and by preserving gastric mucus synthesis and secretion. In rats with WIR stress we have also found a decrease in gastric mucosal constitutive nitric oxide synthase (cNOS) activity and a drastic increase in gastric mucosal inducible nitric oxide synthase (iNOS) activity. The decrease in gastric mucosal cNOS activity is closely related to an increase in neutrophil infiltration into the gastric mucosa and a decrease in the level of gastric mucus. In this study of WIR-stressed rats, therefore, we examined whether the inhibitory actions of teprenone on neutrophil infiltration and decreases in mucus synthesis and secretion in the gastric mucosa of rats are related to the change in gastric mucosal cNOS activity during the development of gastric mucosal lesions. Pre-administration of teprenone (200 mg kg-1) prevented the decrease in gastric mucosal cNOS activity with attenuations of neutrophil infiltration into gastric mucosal tissues and decreased levels of gastric mucosal hexosamine, an index of gastric mucin, and adherent mucus in rats with 3 or 6 h of WIR stress. These preventive effects of teprenone on the gastric mucosal neutrophil infiltration and the decrease in gastric mucus levels in rats with WIR stress were completely reversed with inhibition of gastric mucosal cNOS activity by co-administration of NG-monomethyl L-arginine (L-NMMA), a non-selective NOS inhibitor. These results suggest that the inhibitory actions of teprenone on neutrophil infiltration and decreases in mucus synthesis and secretion in the gastric mucosa of rats with WIR stress are closely related to the maintenance of cNOS activity in the gastric mucosal tissue.
最近,我们证实,抗溃疡药物替普瑞酮对水浸束缚(WIR)应激诱导的大鼠胃黏膜损伤具有保护和预防作用,其作用机制是抑制中性粒细胞浸润到胃黏膜组织,并维持胃黏液的合成与分泌。在WIR应激大鼠中,我们还发现胃黏膜组成型一氧化氮合酶(cNOS)活性降低,而胃黏膜诱导型一氧化氮合酶(iNOS)活性急剧增加。胃黏膜cNOS活性降低与中性粒细胞浸润到胃黏膜增加以及胃黏液水平降低密切相关。因此,在这项关于WIR应激大鼠的研究中,我们检测了替普瑞酮对大鼠胃黏膜中性粒细胞浸润的抑制作用以及胃黏液合成与分泌减少是否与胃黏膜损伤发展过程中胃黏膜cNOS活性的变化有关。预先给予替普瑞酮(200 mg·kg-1)可防止胃黏膜cNOS活性降低,减轻WIR应激3或6小时大鼠胃黏膜组织中的中性粒细胞浸润,并降低胃黏膜己糖胺(胃黏蛋白的一个指标)和附着黏液的水平。通过共同给予非选择性NOS抑制剂NG-单甲基-L-精氨酸(L-NMMA)抑制胃黏膜cNOS活性,替普瑞酮对WIR应激大鼠胃黏膜中性粒细胞浸润和胃黏液水平降低的这些预防作用完全被逆转。这些结果表明,替普瑞酮对WIR应激大鼠胃黏膜中性粒细胞浸润的抑制作用以及胃黏液合成与分泌减少与维持胃黏膜组织中的cNOS活性密切相关。